U.S. government to test Pfizer's Paxlovid for long COVID



The U.S. National Institutes of Health's $1 billion RECOVER Initiative has picked Pfizer Inc's (PFE.N) antiviral drug Paxlovid as the first treatment it will study in patients with long COVID, organizers of the study said on Thursday. Awesome!


Read more about it


Photo Credit: danilo.alvesd

6 views0 comments

Recent Posts

See All